 SEATTLE, Aug. 30, 2022 GLOBE NEWSWIRE -- Nautilus Biotechnology, Inc. NASDAQ: NAUT; or Nautilus, a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be participating in the upcoming Morgan Stanley Global Healthcare Conference in New York, NY. 